Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Virology > Unit 4 - Hepatitis Virus > Flashcards

Unit 4 - Hepatitis Virus Flashcards

1
Q

Describe the History of Viral Hepatitis.

A

Hepatitis—inflammation of the liver

  • Classic symptom—jaundice
  • Caused by a number of viruses and sometimes alcohol or prescription drugs

Hepatitis epidemics in history

  • War: Crowding and unsanitary conditions of military encampments created an ideal environment for hepatitis A viruses to be transmitted.
  • Camp jaundice and outbreaks recorded:
    • Napoleonic Wars
    • U.S. Civil War—camp jaundice
    • WWI—trench warfare
    • WWII—serum hepatitis (via vaccination) and infectious hepatitis (contaminated battle fields)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is hepatitis C and U.S. Military veterans?

A

8%–9% of Veteran Affairs (VA) medical center patients are positive for hepatitis C antibodies.

  • Vietnam era of hepatitis epidemics
  • Combatants survived multiple blood transfusions
  • Intravenous heroin use
  • Sharing of razors and other non-sterile instruments
  • History of tattooing
  • History of prostitution
  • Blood/bodily fluid exposure to healthcare and combat personnel
  • Receipt of contaminated immunoglobulin for hepatitis A prior to hepatitis C screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is epidemiology?

A
  • Yellow fever virus, herpes simplex viruses, cytomegaloviruses, and Epstein-Barr virus can cause hepatitis.
  • A group of unrelated pathogens termed “hepatitis viruses” cause the vast majority of virally-induced hepatitis cases.
  • The focus of this lecture is on the hepatitis viruses.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the hepatitis Virus?

A

Each starts with a letter with the exception of the newly identified transfusion transmission virus (TTV) and SEN viruses.
Hepatitis A
Hepatitis B
Hepatitis non-A, non-B viruses
Hepatitis C
Hepatitis D
Hepatitis E
Hepatitis G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the Clincial Features of hepatitis A?

A
  • Most outbreaks associated with contaminated food or water supplies
  • Shellfish may become contaminated with sewage and may concentrate and retain viruses.
  • Major mode of transmission: fecal–oral
  • Average incubation period: 30 days
  • Adults experience signs and symptoms more often than children.
  • Pregnant women at increased risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the onset symptoms of HAV?

A

Fatigue

Abdominal pain

Loss of appetite

Nausea and vomiting

Dark Urine

Jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Jaundice

A
  • Yellow color in the skin, muscous memberanes, or eyes
  • Occurs when liver is not functioning properly
  • Yellow pigment is from bilirubina byproduct of old red blood cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Hepatitis B (HBV)?

A
  • Relatively rare in developed countries
  • Endemic areas: major model of spread is mother (carrier) to infant (blood of infected mother enters fetus)
  • Other high-risk groups
    • IV drug users
    • Hemodialysis patients
    • Persons with multiple sex partners
    • Institutionalized patients
    • Healthcare workers
  • Average incubation period is 80 days.
  • 30% of individuals have no signs and symptoms
  • If symptoms occur, they are similar to hepatitis A but with joint pain.
  • Chronic hepatitis B infections occurs in 5%–10% of cases.
  • Chronic infections lead to:
    • Cirrhosis of liver
    • Hepatocellular carcinoma (HCC) or liver cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Hepatocellular (Liver) Cancer (HCC)?

A
  • HBV DNA sequences are found in HCC tumor DNA
  • Integration of HBV DNA occurs in breaks in cellular DNA of hepatocytes (liver cells)
  • Chronic HBV infections cause ongoing inflammatory responses and oxidative damage to chromosomal DNA of hpatocytes
  • Death from chronic liver disease result in 15%-25% of individuals
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is hepatitis C?

A

Prior to 1989: Cases of hepatitis of unknown etiology (hepatitis A and B viruses ruled out)
These cases were referred to as “hepatitis non-A, non-B” viruses.
1989: Scientists found a new viral genome present in infectious plasma.
Eventually the new viral pathogen was identified, as it was visualized by TEM, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the major public health problem with heaptitis C?

A
  • “Silent epidemic”- many infected people show few or no signs of disease for years, even decades.
  • Contaminated hemophilia blood products.
  • HCV infection is common in the developed world.
  • 4 million people in United States
  • Up to 170 million people worldwide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is HCV transmission?

A
  • Incubation period: 6–7 weeks
  • Spread almost exclusively through blood contact
  • Individuals who received blood products before 1992 are at risk for contracting HCV.
  • Donated blood screening for HCV did not begin until 1992.
  • 80% of those infected are asymptomatic; if signs or symptoms are present, they resemble other hepatitis infections.
  • Between 55% and 85% of infected persons experience a chronic infection, resulting in chronic liver disease.
  • Chronic infection can lead to cirrhosis of the liver and HCC in 5%–20% of infected persons.
  • April 2013: Oral surgeon in Oklahoma cited for sterilization violations
  • 3,200 patients screened for HIV, HBV, and HBV
  • 57 patients tested positive for HCV
  • 3 patients tested positive for HBV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Hepatitis D (HDV)?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Hepatitis E (HEV)?

A
  • HEV is endemic in the developing countries of Asia and Africa.
  • HEV is rare in industrialized nations.
  • Sporadic cases have been reported in the United States, France, Italy, and the United Kingdom
  • Mode of transmission: similar to HAV (fecal–oral route)
  • Person-to-person transmission rare
  • Incubation period: 40 days (average)
  • Outbreaks are often associated with fecally contaminated water supplies.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HEV causes a more severe Illness than HAV

A
  • HEV causes 1%–3% mortality (general population).
  • HEV causes 15%–25% mortality in pregnant women.
  • Some evidence that hepatitis E may be a zoonotic disease (from pigs)
  • Human HEV isolates are genetically similar to pig HEV strains isolated from pigs in the United States.
  • Pig HEV can infect non-human primates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What hepatitis agents are not A-E?

A

Hepatitis G (HGV)

  • Isolated from plasma of a surgeon in 1996
  • Clinical significance unclear

Sentinel virus (SEN)

  • Identified in 2000
  • May be responsible for the 10% of transfusion-associated hepatitis with no known origin

Transfusion transmission virus or torque teno virus (TTV)

  • Apparently identified in Japanese post-transfusion hepatitis patients in 1997
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the Lab Diagnosis of viral hepatitis infections based on?

A
  • Symptoms (jaundice)
  • Blood tests for liver enzymes
  • Viral antibodies (e.g., IgM)
  • Viral genetic material (e.g., RT-PCR or PCR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the blood samples that are tested for Two Liver enzymes?

A 
Aspartate aminotransferase (AST)
 Alanine aminotransferase (ALT)

These enzymes are normally found in the liver but spill into the blood if the liver is damaged, thus raising the enzyme levels in the blood.

Nucleic acid tests (PCR, RT-PCR) to detect viral genomes are only available in specialized laboratories.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Viral hepatitis diagnosis?

A
  • Patients with chronic hepatitis are harder to diagnose because these patients do not have nausea or jaundice until the liver damage is very advanced.
  • Serology
  • detection of IgM antibodies) is used to detect HAV, HBV, and HCV.
  • Antibodies against HBV surface antigen (HBsAg) or HBV core antigen (HBCAg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the Screening of the Blood Supply for viral hepatitis agents?

A

American Red Cross began screening for:
1971: Hepatitis B surface antigen
1987: HBcAg antibodies
1986–2003: elevated alanine aminotransferase levels
1990: HCV antibodies
1999: nucleic acid test for HCV genomes
Blood is not screened for other hepatitis viruses.
U.S. blood supply is one of the safest in the world.

21
Q

What is the Pathogeneisis of Chronic hepatitis?

A

Chronic hepatitis
Active inflammation of liver (liver biopsy)
Persists for more than 6 months
Increased alanine aminotransferase (ALT) in serum
Hepatitis B, C, D, and G viruses cause chronic hepatitis infections.
Chronic liver damage may result in cirrhosis.
Formation of fibrous tissues, nodules, scarring that interferes with liver function and blood circulation
Late complication of chronic hepatitis is HCC.

22
Q

What is the Hepatitis Virus Life Cycle?

A
  • Hepatitis viruses belong to 5 different families.
  • Two of the hepatitis viruses are unassigned.
  • Five of the eight viruses (hepatitis viruses A–E) have been well characterized.
23
Q

What is the Virus Structure for Hepatitis A-E?

A

Spherical shaped and icosahedral symmetry
28–50 nm in diameter
Enveloped (B, C, D) or non-enveloped (A or E)
Hepatitis B, C, and D are sensitive to many physical and chemical agents
Hepatitis A viruses are acid- and bile-resistant
Hepatitis A can remain infectious on inanimate surfaces for a month

24
Q

What is involved in Virus Replication?

A

Hepatitis viruses enter the bloodstream.
Carried to the liver
Infect the hepatocytes
As hepatocytes are damaged, liver cirrhosis and liver function are impaired.
Liver important in metabolism, filtration of toxins and waste, digestion (bile), and synthesis (amino acids, coagulation factors, etc.)

25
Q

Describe Hepatitis A.

A
  • Very stable in the environment
  • Naked picornavirus
  • +ssRNA genome that is 7.5 kb in length
  • Viral genome and poly (A) tail at the 3′ terminus of the genome
  • 5′ end of the genome contains a non-translated region of hairpins and pseudoknots.
  • Hairpin structures act as internal ribosomal entry sites (IRES) that are necessary for cap-independent translation of the viral mRNA.
26
Q

What is involved in HAV mRNA Translation?

A

The +ssRNA viral genome acts directly as an mRNA for the synthesis of a large polyprotein.
Similar to polioviruses (see Chapter 11)

The polyprotein is processed by a viral 3C protease into structural and nonstructural proteins of the virus.

27
Q

What is involved in HAV genome Replication and Particle Assembly?

A
  • A Viral RNA-dependent RNA polymerase encoded by the 3D gene synthesizes new - ssRNA intermediates used to create progeny genomic +ssRNAs
  • Newly assembled particles are transported to the surface of heptocytes and are exported
28
Q

Describe Hepatits B virus

A

Initial characterization of hepatitis B infections

  • Baruch Blumberg collected blood samples from hemophiliacs (exposed to many donor serum proteins).
  • 1963: Antibodies in the serum of a New York hemophiliac reacted with an antigen present in the blood of an Australian aborigine infected with hepatitis.
    • Australia antigen was the hepatitis B surface antigen (HBsAg).
    • Further experiments by David Dane led to the discovery of the Dane particle (complete infectious hepatitis B virus).
29
Q

What are the Three types of Hepatitis B Particles present during infection during Infection?

A
  • Most abundant HBV particle in carriers is a spherical 17–25 nm particle.
  • Less numerous are non-infectious filamentous particles that are up to 200 nm in length.
  • Dane particles (infectious) are 42 nm in diameter, and enveloped.
  • Dane particle contains the viral DNA polymerase (RT), protein kinase C, and heat shock 90 protein associated with the viral genome.
30
Q

What is the HBV genome?

A
  • Ciricular partially dsDNA
  • Full length strand is 3.2 kb
  • Shorter strand is 1.7 kb length
  • Uses a replication strategy common to retroviruses
    • replicate through an RNA intermediate via reverse transciption
31
Q

Describe HBV attachment and Entry?

A
  • Host receptor is unknown; possibilities include:
    • Transferrin receptor
    • Human liver endonexin
    • Asialoglycoprotein receptor molecule
  • Hepatitis B grows poorly in cell culture—difficult to study molecular mechanisms of viral attachment and entry
  • After fusion and entry—uncoating step
32
Q

What is Uncoating/Genome Replication?

A
  • During uncoating, viral cores are released into the cytoplasm.
  • Genome uncoats and enters the nucleus through the nuclear pores.
  • Host enzymes ligate the ends of the genome.
  • DNA synthesis is completed; gaps are repaired in both DNA strands.
  • Genome is now a closed circular plasmid-like dsDNA molecule called an episome.
  • The episome replicates independently of the host chromosome.
  • HBV DNA does not integrate into the host chromosome (not integrase activity).
33
Q

What is the HBV Episome?

A

Acts as a template for two classes of viral transcripts:

  • Viral pregenomic RNA transcripts
  • Genomic RNA transcripts transcribed by the host’s RNA polymerase II

HBV genome has compact coding organization

  • 4 promoters
  • 2 enhancers
  • 4 partially overlapping ORFs translated into 7 proteins (see Table 17-4)
  • Several binding sites on genome recognized by transcription factors
34
Q

What is the coinfection of HBV and HDV?

A
  • HDV is a defective virus.
  • Requires the presence of a “helper” HBV to assemble mature virions
  • The surface or outer coat of HDV consists of HBsAgs.
  • HDV is associated with chronic hepatitis.
  • HDV probably uses the same cellular receptor as HBV.
35
Q

What is the HDV genome replication?

A
  • RNA genome has intramolecular basepairing.
  • During uncoating, the viral envelope is removed inside of an infected cell and is targeted to the nucleus.
  • The cellular RNA polymerase II and other host factors replicate the viral genome.
  • The HDV genome is a ribozyme- cleaves itself.
  • Genome replication occurs via a rolling circle mechanism similar to that of viroids (see Chapter 19).
36
Q

What is the hepatitis C virus (HCV)?

A
  • Icosahedron-shaped, enveloped virus
  • +ssRNA flavivirus
  • Not much information known about HCVs’ ultrastructure
  • The only flavivirus that is not transmitted by arthropods
  • Similar to picornaviruses (e.g., poliovirus) except that HCV particles are enveloped
  • Viral nucleic acid cloned in 1989
37
Q

What is the HCV genome?

A
  • 9.2 kb in length
  • Contains an internal ribosome entry site (IRES)
  • One long ORF that encodes a polyprotein precursor that is cleaved into nonstructural and structural proteins by cellular and viral proteases
  • Viral genome is translated by host ribosomes
  • NS5b gene encodes its own RNA-dependent RNA polymerase
  • Viral entry receptors: clathrin, CD81, SR-B1
  • IFN resistance correlated with the HCV E1 and E2 proteins
38
Q

What is Hepatitis E genome (HEV)?

A
  • +ssRNA genome
  • Clinically indistinguishable from HAV infection
  • HEV particles less stable than HAV
  • Non-enveloped, icosahedral-shaped
  • 32–34 nm in diameter
  • 7.2 kb genome (contains short 5′ and 3′ noncoding regions)
  • 3′ end contains a poly(A) tail
39
Q

Describe the HEV genome?

A

Lack of molecular biology information available
No suitable cell culture system to propagate HEV
Three overlapping ORFs
ORF1 (non-structural proteins like protease and replicase)
ORF2 (structural proteins; capsid)
ORF3 (small phosphoprotein of unknown function)

40
Q

What is tht ePathophysiology of chronic hepatitis virus infections?

A
  • The enveloped viruses (HBV, HCV, HDV, HGV) cause persistent and chronic infections.
  • These viruses possess immune evasion strategies.
  • HBV reactivation in livers from HBV-immune donors
  • HBV likely exists in hepatocytes in a latent form for a long time
  • Liver damage caused by HBV and HCV may result from an autoimmune reaction directed against hepatocyte antigens initiated by viral infection.
41
Q

What is the management and prevention of hepatitis A-E virus?

A

Hepatitis A management

  • No specific treatment
  • Supportive care

Prevention: handwashing and proper sanitary disposal of human feces

  • Passive immunity (immunoglobulin) 85% effective in preventing disease if given with 2 weeks of exposure

HAV vaccine: formalin-inactivated, cell culture produced whole-vaccines

  • Injections at 0, 6, and 12 months in individuals > 2 yrs old
  • Live-attenuated vaccines being tested
42
Q

What is involved in HBV management and Prevention?

A
  • Basic goal is to stop viral replication and prevent end-stage liver disease
  • Three licensed drugs to treat HBV
    • Interferon -2b (46% response rate; many side effects)
    • Lamivudine (RT inhibitor)
    • Adefovir dipivoxil (RT inhibitor)
  • Immunoglobulin used as an adjunct to HBV vaccine in preventing HBV transmission from an infected mother to fetus
    • 70-90% of infants born to HBeAg-positive mothers become infected at birth and develop chronic HBV
43
Q

What are the HBV Vaccines?

A
  • Early vaccines were prepared by harvesting spherical particles from plasma of chronically infected individuals.
  • Particles purified and inactivated by heat, formaldehyde, urea, or pepsin
  • Subsequently, vaccine manufacturers used genetic engineering to express HBsAg in yeast.
  • Purified HBsAg self assembles into spherical particles resembling 17–25 nm particles found in the serum of people with chronic hepatitis.
  • Safe; noninfectious particle
44
Q

What are HBV Vaccine REcommendations by the CDC?

A
  • Newborns should receive a birth dose before leaving the hospital
  • Children age 19 and under should recieve the HBV vaccine series
  • HBV accine is the first vaccine to prevent a cancer
  • Between 1990 and 2002 the incidence of heptatits B-related liver cancer decreased 67%.
45
Q

How is HCV managed?

A

85% of HCV infections progress to chronic liver disease
No vaccine available
HCV has a high mutation rate
Current therapies to manage HCV infection:
Pegylated interferon and
Ribavirin (nucleoside analog)
75% cure rate, but takes up to 1 year and has debilitating side-effects
Sofosbuvir (nucleotide analog); now in clinical trials
97-99% virus eliminated after 12 week treatment when combined with ribavirin
Response to therapy is measured by levels of serum transaminases and detection of HCV RNA.
Six main genotypes of HCV
Certain genotypes respond better to treatment than others

46
Q

What is the breakthrough for a hepatitis C virus research?

A

1989: HCV discovered
2005: entire viral genome isolated and sequenced
RNA inserted to human liver cell line (Huh-7.5 cells)
Infectious particles produced for study

47
Q

What is HDV and HEV Management?

A

HDV infections maintained by reducing HBV replication

  • Interferon, lamivudine, adeovir
  • No immune globulin or HDV vaccine

HEV infections usually self-limiting

  • Treatment is supportive
  • No immunoglobulin or HEV vaccine available
  • Focus on prevention
48
Q
A

Virology (23 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions